The The Rare Case of Metastatic Lesion of the Seminal Vesicle in Non-Muscle Invasive Bladder Cancer

CLINICAL CASES

https://doi.org/10.37469/0507-3758-2025-71-2-OF-2209

Published 30.04.2025

Liudmila A. Strokova⁺⁻
Kirill V. Bagrey⁺⁻
Alexander S. Grishchenkov⁺⁻
Irina A. Bekhtereva⁺⁻
Ilgam Z. Bikbov⁺⁻

Liudmila A. Strokova

1NWDSCC named after L.G. Sokolov Federal Medical and Biological Agency, St. Petersburg, Russian Federation 2Private Academy of Medical Education named after F.I. Inozemtsev, St. Petersburg, Russian Federation

https://orcid.org/0000-0002-2053-6502

Kirill V. Bagrey

NWDSCC named after L.G. Sokolov Federal Medical and Biological Agency, St. Petersburg, Russian Federation

https://orcid.org/0009-0009-8011-5775

Alexander S. Grishchenkov

1NWDSCC named after L.G. Sokolov Federal Medical and Biological Agency, St. Petersburg, Russian Federation 3Almazov National Medical Research Centre, St. Petersburg, Russian Federation

https://orcid.org/0000-0003-0910-6904

Irina A. Bekhtereva

1NWDSCC named after L.G. Sokolov Federal Medical and Biological Agency, St. Petersburg, Russian Federation 4 North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russian Federation 5Private University «Saint-Petersburg Medico-Social Institute», St. Petersburg, Russian Federation

https://orcid.org/0000-0002-5206-3367

Ilgam Z. Bikbov

Almazov National Medical Research Centre, St. Petersburg, Russian Federation

https://orcid.org/0009-0007-2098-5045

##article.numberofdownloads## 19

##article.numberofviews## 22

pdf (Русский)

Keywords

non-muscle invasive bladder cancer
distant metastasis
seminal vesicle
ultrasound examination
magnetic resonance imaging

How to Cite

Strokova, L. A., Bagrey, K. V., Grishchenkov, A. S., Bekhtereva, I. A., & Bikbov, I. Z. (2025). The The Rare Case of Metastatic Lesion of the Seminal Vesicle in Non-Muscle Invasive Bladder Cancer. Voprosy Onkologii, 71(2), OF–2209. https://doi.org/10.37469/0507-3758-2025-71-2-OF-2209

Abstract

Bladder cancer is the most common malignant neoplasm of the urinary tract. Non-muscle invasive bladder cancer accounts for about 70 % of all new cases of this disease. In this form of the malignant process, distant metastasis without local progression is an extremely rare phenomenon. This article presents a clinical case of successful diagnosis of metastatic lesions of the seminal vesicle in non-muscle invasive bladder cancer. Following investigation, including a puncture biopsy of the seminal vesicle, the patient underwent a course of multi-agent chemotherapy and to date has shown no signs of recurrence of the oncological process.

https://doi.org/10.37469/0507-3758-2025-71-2-OF-2209

##article.numberofdownloads## 19

##article.numberofviews## 22

pdf (Русский)

References

Sung H., Ferlay J., Siegel RL., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3): 209-249.-DOI: 10.3322/caac.21660.

Каприн А.Д., Старинский В.В., Шахзадова А.О. Злокачественные новообразования в России в 2023 году. Заболеваемость и смертность. Под ред. Каприна А.Д., Старинского В.В., Шахзадовой А.О. М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024; 276.-ISBN 978-5-85502-298-8. [Kaprin A.D., Starinsky V.V., Shakhzadova A.O. Malignant neoplasms in Russia in 2019. Morbidity and mortality. Ed. by Kaprin A.D., Starinsky V.V., Shakhzadova A.O. M.: P.A. Herzen Moscow State Medical Research Institute − branch of the Federal State Budgetary Institution "NMIC of Radiology" of the Ministry of Health of the Russian Federation, 2024; 276.-ISBN 978-5-85502-298-8 (In Rus)].

Isharwal S., Konety B. Non-muscle invasive bladder cancer risk stratification. Indian J Urol. 2015; 31(4): 289-96.-DOI: 10.4103/0970-1591.166445.

Suarez-Ibarrola R., Soria F., Abufaraj M., et al. Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour. BJU Int. 2019; 123(4): 646-650.-DOI: 10.1111/bju.14557.

Hurle R., Contieri R., Casale P., et al. Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure. Urol Oncol. 2021; 39(3): 195.e7-195.e13.-DOI: 10.1016/j.urolonc.2020.09.017.

Stein J.P., Lieskovsky G., Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19(3): 666-75.-DOI: 10.1200/JCO.2001.19.3.666.

Matthews P.N., Madden M., Bidgood K.A., et al. The clinicopathological features of metastatic superficial papillary bladder cancer. J Urol. 1984; 132(5): 904-6.-DOI: 10.1016/s0022-5347(17)49939-3.

Xu T., Gu W., Wang X., et al. Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature. World J Surg Oncol. 2022; 20(1): 226.-DOI: 10.1186/s12957-022-02664-5.

Garrido-Abad P., Martin L.G., Zarra K.V., et al. Metastatic non-muscle invasive bladder can-cer with cervical lymph node metastasis. Int Braz J Urol. 2019; 45(6): 1270-1274.-DOI: 10.1590/S1677-5538.IBJU.2018.0421.

Woldu S.L., Bagrodia A., Lotan Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2017; 119(3): 371-380.-DOI: 10.1111/bju.13760.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.